Aryl hydrocarbon receptor (AhR), an environment-sensing xenobiotic receptor and ligand-activated transcription factor vital for skin immune homeostasis and barrier maintenance, has attracted attention as a therapeutic target for both AD and psoriasis [16–20]. This evidence concerns the gene AHR and psoriasis.